| Primary |
| Multiple Myeloma |
25.7% |
| Product Used For Unknown Indication |
21.4% |
| Anaemia |
11.4% |
| Anaemia Of Malignant Disease |
5.7% |
| Antiviral Prophylaxis |
5.7% |
| Anxiety |
5.7% |
| Bone Pain |
5.7% |
| Insomnia |
5.7% |
| Non-small Cell Lung Cancer |
4.3% |
| Depression |
2.9% |
| Antibiotic Prophylaxis |
1.4% |
| Cancer Pain |
1.4% |
| Nephrogenic Anaemia |
1.4% |
| Pain |
1.4% |
|
| Urinary Tract Infection |
33.3% |
| Sepsis |
16.7% |
| Cardiac Disorder |
8.3% |
| Pneumonia |
8.3% |
| Pulmonary Embolism |
8.3% |
| Pulmonary Toxicity |
8.3% |
| Renal Failure Chronic |
8.3% |
| Unevaluable Event |
8.3% |
|
| Secondary |
| Product Used For Unknown Indication |
15.8% |
| Drug Use For Unknown Indication |
13.8% |
| Nephrogenic Anaemia |
12.8% |
| Anaemia |
7.4% |
| Blood Pressure |
7.2% |
| Systemic Lupus Erythematosus |
7.2% |
| Renal Failure Chronic |
4.3% |
| Hypertension |
3.8% |
| Acidosis |
3.6% |
| Hyperphosphataemia |
3.6% |
| Osteoporosis |
3.6% |
| Peptic Ulcer |
3.6% |
| Hepatitis C |
2.8% |
| Multiple Myeloma |
2.3% |
| Immunosuppression |
1.9% |
| Dialysis |
1.7% |
| Coronary Artery Disease |
1.5% |
| Infection |
1.1% |
| Renal Failure |
1.1% |
| Anaemia Of Malignant Disease |
1.0% |
|
| Therapeutic Response Decreased |
20.8% |
| Aplasia Pure Red Cell |
13.4% |
| Renal Transplant |
8.2% |
| Oesophagitis |
6.1% |
| Mouth Ulceration |
5.6% |
| Sepsis |
5.6% |
| Sideroblastic Anaemia |
4.8% |
| Haemoglobin Decreased |
4.3% |
| Pneumonia |
4.3% |
| Renal Failure |
3.5% |
| Renal Failure Chronic |
3.5% |
| Posterior Reversible Encephalopathy Syndrome |
2.6% |
| Transplant Rejection |
2.6% |
| Urinary Tract Infection |
2.6% |
| Drug Ineffective |
2.2% |
| Renal Impairment |
2.2% |
| Thymoma |
2.2% |
| Wegener's Granulomatosis |
2.2% |
| Haematocrit Decreased |
1.7% |
| Postictal State |
1.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
26.6% |
| Product Used For Unknown Indication |
18.0% |
| Multiple Myeloma |
8.9% |
| Anaemia |
6.7% |
| Hepatitis C |
5.6% |
| Prophylaxis |
5.5% |
| Non-small Cell Lung Cancer |
4.3% |
| Hypertension |
3.7% |
| Renal Transplant |
3.1% |
| Renal Failure Chronic |
2.8% |
| Constipation |
2.1% |
| Peritoneal Dialysis |
1.9% |
| Pain |
1.6% |
| Plasma Cell Myeloma |
1.4% |
| Diabetes Mellitus |
1.4% |
| Insomnia |
1.4% |
| Infection Prophylaxis |
1.3% |
| Prophylaxis Of Nausea And Vomiting |
1.3% |
| Thrombosis Prophylaxis |
1.2% |
| Hyperparathyroidism Secondary |
1.1% |
|
| Thrombocytopenia |
12.3% |
| Vomiting |
12.0% |
| Death |
6.8% |
| Varicella |
6.2% |
| Renal Failure |
5.5% |
| Myocardial Infarction |
4.9% |
| Pneumonia |
4.5% |
| Renal Failure Acute |
4.5% |
| Transplant Rejection |
4.5% |
| Cardiac Arrest |
3.9% |
| Pulmonary Embolism |
3.9% |
| Pyrexia |
3.9% |
| Sinusitis |
3.9% |
| Sepsis |
3.6% |
| Urine Output Decreased |
3.6% |
| White Blood Cell Count Decreased |
3.6% |
| Dyspnoea |
3.2% |
| Septic Shock |
3.2% |
| Anaemia |
2.9% |
| General Physical Health Deterioration |
2.9% |
|
| Interacting |
| Product Used For Unknown Indication |
50.0% |
| Hepatitis C |
25.0% |
| Anxiety |
12.5% |
| Drug Use For Unknown Indication |
12.5% |
|
| Ventricular Fibrillation |
66.7% |
| Hypotension |
33.3% |
|
